Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Nanostart-held ItN Nanovation receives equity commitment to support continued growth

December 10, 2010 8:34 am | by I-Micronews | News | Comments

ItN Nanovation AG, a portfolio company of Nanostart AG, has announced the signing of a conditional equity investment agreement of up to EUR 15 million with YA Global Master SPV Ltd., which is managed by Yorkville Advisors, LLC, a large U.S.-based investment group.

International collaboration boosts nanotechnology research

December 10, 2010 8:34 am | by I-Micronews | News | Comments

Despite their initial focus on national economic competitiveness, the nanotechnology research initiatives now funded by more than 60 countries have become increasingly collaborative, with nearly a quarter of all papers co-authored by researchers across borders.

Denosumab Delayed Time to First Skeletal-related Side Effect

December 10, 2010 8:32 am | by AACR | News | Comments

SAN ANTONIO - For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.

TOPICS:
Advertisement

Photonics21 event to focus on FP8 priorities

December 10, 2010 7:37 am | by I-Micronews | News | Comments

European Commissioner Neelie Kroes will make a keynote address at the annual meeting of the Photonics21 European Technology Platform.

Innovative Micro Technology adds to its arsenal of through-silicon via offering

December 10, 2010 7:36 am | by I-Micronews | News | Comments

Innovative Micro Technology, Inc. (IMT) announced today the addition of a new geometry point in its technology roadmap for Through Silicon Vias (TSVs).

TSMC announces 3DIC Chip Technologies using TSVs

December 10, 2010 7:36 am | by I-Micronews | News | Comments

Taiwan Semiconductor Manufacturing Co Ltd (TSMC) had a lecture on its efforts to mass-produce 3D chips made by three-dimensionally stacking semiconductor chips by using its TSV (through silicon via) technology.

SABCS 2010: Interview with Ivis Febus-Sampayo

December 10, 2010 7:35 am | by AACR | News | Comments

Ms. Febus-Sampayo discusses the cultural challenges faced by Latina women when they receive a cancer diagnosis, shares advice about how clinicians can best serve the Latina women who have cancer, and the long-term goals of her organization.

TOPICS:

New Poll: Voters Want to Reduce Wasteful Spending in Medicaid Pharmacy

December 10, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Dec. 10, 2010 /PRNewswire-USNewswire/ -- Voters would rather reduce Medicaid spending by better managing pharmacy benefits rather than cutting benefits for patients or payments to doctors and hospitals, according to a new poll commissioned by the Pharmaceutical Care Management...

TOPICS:
Advertisement

Advanced BioHealing Appoints Kevin C. O'Boyle as Chief Financial Officer

December 10, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

WESTPORT, Conn., Dec. 10, 2010 /- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine , today announced the appointment of Kevin C. O'Boyle, as Senior Vice President and Chief Financial Officer. (Photo:...

TOPICS:

Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder

December 10, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Dec. 10, 2010 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced today the pricing of the previously announced public offering of 2,000,000 shares of its common stock by Ares Corporate Opportunities Fund, L.P. at a public offering price of $20.00 per share.  The...

TOPICS:

SABCS 2010: Interview with Carlos L. Arteaga, M.D.

December 10, 2010 7:34 am | by AACR | News | Comments

Dr. Arteaga discusses targeted drugs for breast cancer, endocrine resistance, clinical trial enrollment criteria and his reactions to some of the important presentations at this year's symposium.

TOPICS:

SABCS 2010: Interview with Chi Van Dang, M.D., Ph.D.

December 10, 2010 7:34 am | by AACR | News | Comments

Dr. Dang discusses the major points of his plenary session, “Oncogenic Reprogramming of Metabolism and Therapy,” including how oncogenic alterations in cancers lead to altered tumor metabolism, and the function of the c-myc oncoprotein, which has emerged as a central oncogenic switch in...

TOPICS:

SABCS 2010: Interview with Stacy L. Moulder, M.D.

December 10, 2010 7:33 am | by AACR | News | Comments

Dr. Moulder talks about her research on PARP inhibitors for hard-to-treat breast cancers, such as triple-negative breast cancer, and the collaborative team that continues this line of research.

TOPICS:

SABCS 2010: Interview with George W. Sledge Jr., M.D.

December 10, 2010 7:33 am | by AACR | News | Comments

Dr. Sledge talks about the results of the first large nationwide study on the use of Taxol for advanced breast cancer, his perspective on new therapies for breast cancer, and his goals as president of the American Society of Clinical Oncology.

TOPICS:

BG Medicine plans IPO of up to $71.2M

December 10, 2010 6:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

BG Medicine Inc., the Waltham-based developer of biomarker-based diagnostic tools, is expected to announce an initial public offering of up to $71.2 million, according to a regulatory filing. The 4.7 million shares, planned for between $13 and $15, is expected to be priced next week, a...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading